Clinical Trial

Neostigmine and Glycopyrrolate by Iontophoresis

Name: Neostigmine and Glycopyrrolate by Iontophoresis — clinical trial record (NCT06351995)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-04-01; most recent amendment 2025-02-26.

Status change: Active, Not Recruiting → Completed 2025-02-26

Trial Details

NCT Number	NCT06351995
Lead Sponsor	James J. Peters Veterans Affairs Medical Center
Conditions	Spinal Cord Injuries, Constipation, Fecal Incontinence, Neurogenic Bowel
Enrollment	6 participants
Start Date	2020-11-06
Primary Completion	2022-10-25 (estimated)
Study Completion	2025-01-01 (estimated)
Updated on ClinicalTrials.gov	2024-04-08